These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 498165)

  • 1. Melphalan in metastatic cancer of the prostate.
    Franks CR
    Cancer Treat Rev; 1979 Jun; 6 Suppl():121-5. PubMed ID: 498165
    [No Abstract]   [Full Text] [Related]  

  • 2. Melphalan in metastatic cancer of the prostate: a pilot study.
    Franks CR
    Cancer Treat Rep; 1979 Feb; 63(2):228-9. PubMed ID: 445500
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report.
    Kvols LK; Eagan RT; Myers RP
    Cancer Treat Rep; 1977; 61(2):311-2. PubMed ID: 326400
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistochemistry of prostatic acid phosphatase.
    Nadji M; Morales AR
    Ann N Y Acad Sci; 1982; 390():133-41. PubMed ID: 7046588
    [No Abstract]   [Full Text] [Related]  

  • 5. Serial carcinoembryonic antigen assays in patients with metastatic carcinoma of prostate being treated with chemotherapy.
    Kane RD; Mickey DD; Paulson DF
    Urology; 1976 Dec; 8(6):559-62. PubMed ID: 997050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy.
    Grignon D; Troster M
    Prostate; 1985; 7(2):195-202. PubMed ID: 2413432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
    Bruce AW; Mahan DE; Sullivan LD; Goldenberg L
    J Urol; 1981 Mar; 125(3):357-60. PubMed ID: 6162968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histochemical and biochemical enzyme studies in prostatic carcinomatous tissue before and during treatment with estrogen.
    Nilsson T; Müntzing J
    Scand J Urol Nephrol; 1973; 7(1):14-7. PubMed ID: 4701653
    [No Abstract]   [Full Text] [Related]  

  • 9. Carcinoma of the prostate: treatment with external radiotherapy.
    Harisiadis L; Veenema RJ; Senyszyn JJ; Puchner PJ; Tretter P; Romas NA; Chang CH; Lattimer JK; Tannenbaum M
    Cancer; 1978 Jun; 41(6):2131-42. PubMed ID: 657085
    [No Abstract]   [Full Text] [Related]  

  • 10. Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase.
    Yuksel M; Cermik TF; Kaya M; Salan A; Ustun F; Salihoglu YS; Yigitbasi ON; Berkarda S
    Clin Nucl Med; 2001 Nov; 26(11):962. PubMed ID: 11595863
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of prostatic carcinoma presenting as a metastatic orbital tumor].
    Sakai H; Igawa T; Saha PK; Nomata K; Yushita Y; Kanetake H; Saito Y
    Hinyokika Kiyo; 1992 Jan; 38(1):77-80. PubMed ID: 1546575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatment of advanced prostatic cancer: development of a new system for defining response.
    Citrin DL; Cohen AI; Harberg J; Schlise S; Hougen C; Benson R
    J Urol; 1981 Feb; 125(2):224-7. PubMed ID: 6259376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of adriamycin (NSC-123127) and 5-fluorouracil (NSC-19893) in advanced prostatic cancer.
    DeWys WD
    Cancer Chemother Rep; 1975; 59(1):215-7. PubMed ID: 1093668
    [No Abstract]   [Full Text] [Related]  

  • 14. Metastatic carcinoma to the sphenoid sinus. Case report and review of the literature.
    McClatchey KD; Lloyd RV; Schaldenbrand JD
    Arch Otorhinolaryngol; 1985; 241(3):219-24. PubMed ID: 3896212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
    Broghamer WL; Richardson ME; Faurest S; Parker JE
    Acta Cytol; 1985; 29(3):274-8. PubMed ID: 3890441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic acid phosphatase: its current clinical status.
    Heller JE
    J Urol; 1987 Jun; 137(6):1091-103. PubMed ID: 3295298
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial chemotherapeutic trials in patients with inoperable or recurrent cancer of the prostate.
    Tejada F; Cohen MH
    Cancer Chemother Rep; 1975; 59(1):243-9. PubMed ID: 1131804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hormone-sensitive metastatic prostate cancer. Update on hormonal therapy.
    Figg WD; Feuer JA; Bauer KS
    Cancer Pract; 1997; 5(4):258-63. PubMed ID: 9250085
    [No Abstract]   [Full Text] [Related]  

  • 19. Melphalan in advanced prostatic cancer: a pilot study.
    Houghton AL; Robinson MR; Smith PH
    Cancer Treat Rep; 1977 Aug; 61(5):923-4. PubMed ID: 890698
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum prostatic acid phosphatase: an increase associated with a metastatic carcinoid tumor.
    Martini F; Pannacciulli I
    J Natl Cancer Inst; 1991 Apr; 83(7):511. PubMed ID: 2005634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.